Trump Administration Announces New Tariffs on Pharmaceuticals

The Trump administration announced new tariffs on pharmaceuticals while also rolling back levies on certain metals. These changes aim to simplify duties affecting trade relations and may impact market prices for pharmaceutical companies. The specific tariff rates on pharmaceuticals were not detailed in the announcement. This decision could influence trading volumes for affected sectors as companies respond to the adjusted trade conditions.